Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC

5 Nov 2024

Abstract excerpt

Background and Objective: Lung cancer, the second most prevalent cancer globally, poses significant challenges in early detection and prognostic assessment. Despite advancements in targeted therapies and immunotherapy, the timely identification of relapse remains elusive. Blood-based liquid biopsy biomarkers, including circulating tumor cells (CTCs), cell-free DNA (cfDNA), circulating tumor DNA (ctDNA),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Extracellular vesicles in disease
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39594687
DOI: 10.3390/cancers16223729

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLCPMID 39594687Read ↗

Data Driven Identification of Plasma Metabolite Clusters and Metabolites of Interest for Potential Detection of Early Stage Non-Small Cell Lung Cancer Cases Versus Cancer-Free ControlsSemantic proximity Read ↗

Metabolic profiles of whole serum and serum-derived exosomes are different in head and neck cancer patients treated by radiotherapySemantic proximity Read ↗

Extracellular Vesicle-Associated miRNAs as a Biomarker for Lung Cancer in Liquid BiopsySemantic proximity Read ↗

Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancerSemantic proximity Read ↗

Multi-omic profiling of squamous cell lung cancer identifies metabolites and related genes associated with squamous cell carcinomaSemantic proximity Read ↗

Molecular Profiling of A549 Cell-Derived Exosomes: Proteomic, miRNA, and Interactome Analysis towards Identifying Potential Key Regulators in Lung CancerSemantic proximity Read ↗

Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles.Semantic proximity Read ↗

Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.Semantic proximity Read ↗

Circulating extracellular vesicle-based multianalyte biomarker signatures accurately distinguish glioblastoma from brain metastasis patients before surgerySemantic proximity Read ↗

Extracellular Vesicle Gene Expression Enables Sensitive Detection of Colorectal NeoplasiaSemantic proximity Read ↗

Targeted metabolomic profiling as a tool for diagnostics of patients with non- small-cell lung cancerSemantic proximity Read ↗

A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.